Literature DB >> 8380674

Cerebral protection by adenosine.

P Schubert1, G W Kreutzberg.   

Abstract

Delayed selective nerve cell death as seen in the hippocampal CA1 area of gerbils after transient forebrain ischemia goes along with neuronal hyperactivity and an early demonstrable accumulation of calcium in circumscribed groups of nerve cells. Application of NMDA receptor-blockers such as MK 801 prevents neuronal damage. This suggests the involvement of NMDA receptors which are operated by glutamate and known to mediate a special Ca2+ influx required also for establishing sustained enhancement of synaptic efficacy. Thus, the excessive postischemic accumulation of calcium, thought to be instrumental in the generation of nerve cell death, seems to result from turning on a dangerous, but primarily physiological mechanism which ran out of control. We studied the endogenous control mechanisms by which the firing pattern of nerve cells and the initiation of NMDA receptor-mediated neuronal Ca2+ influx are controlled focusing in particular on the role of adenosine. This nucleoside is released from nerve- and glial cells in larger amounts after ischemia. It counteracts at increased extracellular concentration the generation of burst discharges, an effect which is ascribed to a modulation of the dendritic membrane properties. Removal of a possible action of endogenous adenosine by receptor antagonists such as theophylline was found to enhance postischemic nerve cell death. This together with other reported experimental evidences points to a protective action of this nucleoside in the brain. The presumed mechanisms by which this effect is achieved were studied in a rat hippocampal slice using ion selective electrodes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380674     DOI: 10.1007/978-3-7091-9266-5_12

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  9 in total

Review 1.  Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal.

Authors:  Tracy R Butler; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2011-07-18       Impact factor: 3.455

Review 2.  Pharmacological prophylaxis of post-traumatic epilepsy.

Authors:  A Iudice; L Murri
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

3.  CNS adenosine A1 receptors are altered after the administration of convulsant 3-mercaptopropionic acid and cyclopentyladenosine: an autoradiographic study.

Authors:  L Giraldez; F Zanetti; M C Antonelli; G Rodríguez de Lores Arnaiz; E Girardi
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

4.  Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors.

Authors:  G W Bong; S Rosengren; G S Firestein
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

5.  [Glutamate neurotoxicity during spinal cord ischemia--the neuroprotective effects of adenosine].

Authors:  T Nakamichi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-04

Review 6.  Drug-induced hypothermia in stroke models: does it always protect?

Authors:  Meijuan Zhang; Haiying Wang; Jinbing Zhao; Cong Chen; Rehana K Leak; Yun Xu; Peter Vosler; Jun Chen; Yanqin Gao; Feng Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

7.  Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat.

Authors:  N Braun; Y Zhu; J Krieglstein; C Culmsee; H Zimmermann
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

Review 8.  The role of HIFs in ischemia-reperfusion injury.

Authors:  Neil J Howell; Daniel A Tennant
Journal:  Hypoxia (Auckl)       Date:  2014-07-30

9.  Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer's Disease.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Mireia Casanovas; Alejandro Lillo; Carlos A Saura; Gemma Navarro
Journal:  Cells       Date:  2020-04-26       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.